Noble Partners as of Sept. 30, 2011
Portfolio Holdings for Noble Partners
Noble Partners holds 21 positions in its portfolio as reported in the September 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Us Natural Gas Fd Etf | 35.0 | $8.1M | 900k | 9.01 | |
| Tesla Motors (TSLA) | 16.9 | $3.9M | 160k | 24.39 | |
| Golar Lng Partners Lp unit | 8.3 | $1.9M | 75k | 25.57 | |
| Akorn | 4.4 | $1.0M | 130k | 7.80 | |
| Allergan | 3.9 | $906k | 11k | 82.36 | |
| Cubist Pharmaceuticals | 3.8 | $883k | 25k | 35.32 | |
| Northgate Minerals | 3.6 | $840k | 250k | 3.36 | |
| Perrigo Company | 3.4 | $777k | 8.0k | 97.12 | |
| Salix Pharmaceuticals | 3.2 | $740k | 25k | 29.60 | |
| WellPoint | 3.1 | $718k | 11k | 65.27 | |
| Medicis Pharmaceutical Corporation | 2.4 | $547k | 15k | 36.47 | |
| Elan Corporation | 1.8 | $421k | 40k | 10.52 | |
| Human Genome Sciences | 1.6 | $381k | 30k | 12.70 | |
| Ariad Pharmaceuticals | 1.5 | $352k | 40k | 8.80 | |
| Cardiome Pharma Corp | 1.4 | $316k | 96k | 3.29 | |
| BioSante Pharmaceuticals | 1.3 | $296k | 130k | 2.28 | |
| Jazz Pharmaceuticals | 1.3 | $291k | 7.0k | 41.57 | |
| Amarin Corporation | 1.2 | $276k | 30k | 9.20 | |
| Banro Corp | 1.1 | $257k | 66k | 3.92 | |
| Dendreon Corporation | 0.8 | $180k | 20k | 9.00 | |
| ACADIA Pharmaceuticals (ACAD) | 0.1 | $22k | 20k | 1.10 |
